ADC Therapeutics SA (ADCT) Shareholders’ equity 2022–2025
ADC Therapeutics SA (ADCT) shareholders’ equity at each fiscal year-end, per SEC filings.
-$185.8MFY2025 · since FY2022: $79.5M → -$185.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$185.8M | +8.3% |
| FY2024 | -$202.6M | -36.7% |
| FY2023 | -$148.2M | -286.6% |
| FY2022 | $79.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice